Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma
2 clinical trials · Condition
◉ Watch Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (NCT04660760) | Academic and Community Cancer Research United | 2021-06-16 |
Track Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.